Jerrell Shelton Sells 151,304 Shares of CryoPort, Inc. (NASDAQ:CYRX) Stock

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) CEO Jerrell Shelton sold 151,304 shares of the company's stock in a transaction dated Tuesday, June 17th. The stock was sold at an average price of $6.81, for a total transaction of $1,030,380.24. Following the completion of the transaction, the chief executive officer now owns 912,419 shares of the company's stock, valued at approximately $6,213,573.39. This trade represents a 14.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Jerrell Shelton also recently made the following trade(s):

• On Wednesday, June 18th, Jerrell Shelton sold 119,281 shares of CryoPort stock. The stock was sold at an average price of $6.81, for a total transaction of $812,303.61.
• On Friday, June 20th, Jerrell Shelton sold 69,135 shares of CryoPort stock. The stock was sold at an average price of $6.47, for a total value of $447,303.45.
• On Monday, March 24th, Jerrell Shelton sold 2,980 shares of CryoPort stock. The stock was sold at an average price of $6.94, for a total value of $20,681.20.

CryoPort Stock Up 3.0%

CYRX traded up $0.19 during midday trading on Monday, hitting $6.56. 572,912 shares of the company's stock traded hands, compared to its average volume of 529,975. The company has a market cap of $328.92 million, a PE ratio of -2.80 and a beta of 1.85. The stock's fifty day simple moving average is $6.20 and its 200-day simple moving average is $6.70. The company has a debt-to-equity ratio of 0.51, a current ratio of 5.56 and a quick ratio of 5.24. CryoPort, Inc. has a one year low of $4.58 and a one year high of $9.78.

CryoPort (NASDAQ:CYRX - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. CryoPort had a negative return on equity of 11.03% and a negative net margin of 50.15%. The business had revenue of $41.04 million for the quarter, compared to the consensus estimate of $56.19 million. As a group, equities analysts anticipate that CryoPort, Inc. will post -0.99 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CYRX. Morgan Stanley dropped their price target on CryoPort from $8.00 to $7.00 and set an "equal weight" rating on the stock in a report on Monday, May 5th. Guggenheim restated a "buy" rating and issued a $10.00 target price on shares of CryoPort in a report on Wednesday, April 16th. Roth Mkm reissued a "buy" rating and issued a $15.00 price target on shares of CryoPort in a research report on Tuesday, April 1st. UBS Group boosted their price objective on shares of CryoPort from $10.00 to $11.00 and gave the company a "buy" rating in a research report on Tuesday, April 1st. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $11.00 target price on shares of CryoPort in a research report on Thursday, May 8th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $11.00.

Institutional Trading of CryoPort

Large investors have recently modified their holdings of the company. Cadian Capital Management LP lifted its position in CryoPort by 14.1% during the 4th quarter. Cadian Capital Management LP now owns 4,927,027 shares of the company's stock worth $38,332,000 after acquiring an additional 609,021 shares during the last quarter. Millennium Management LLC grew its position in shares of CryoPort by 11.0% in the fourth quarter. Millennium Management LLC now owns 4,139,869 shares of the company's stock valued at $32,208,000 after purchasing an additional 409,353 shares during the last quarter. LPL Financial LLC increased its stake in shares of CryoPort by 1,366.1% in the fourth quarter. LPL Financial LLC now owns 436,766 shares of the company's stock worth $3,398,000 after purchasing an additional 406,976 shares during the period. Norges Bank acquired a new position in shares of CryoPort during the 4th quarter worth about $2,711,000. Finally, Silvercrest Asset Management Group LLC boosted its stake in CryoPort by 77.0% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 742,914 shares of the company's stock valued at $5,780,000 after purchasing an additional 323,216 shares during the period. 92.90% of the stock is owned by institutional investors.

CryoPort Company Profile

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.